Related Experiment Video
Updated: Nov 16, 2025

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
Cyclic vomiting syndrome: A narrative review and guide to management
1Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Medical College of Wisconsin, Milwaukee, WI, USA.
Insights
Cyclic vomiting syndrome (CVS) is a gut-brain disorder causing severe nausea and vomiting. Early diagnosis and migraine-focused treatments, including lifestyle changes, improve outcomes for affected children and adults.
Area of Science:
- Gastroenterology
- Neurology
- Pediatrics
Background:
- Cyclic vomiting syndrome (CVS) is a disabling gut-brain interaction disorder characterized by severe nausea and vomiting episodes.
- Prevalence affects 1-2% of children, with a recent increase in adult diagnoses.
Purpose of the Study:
- To provide a narrative review of pediatric and adult CVS literature.
- To offer a management guide based on clinical experience.
Main Methods:
- Literature review summarizing current knowledge on CVS.
- Expert consensus diagnostic approach with limited testing.
- Clinical experience guiding management strategies.
Main Results:
- Diagnosis relies on expert consensus and exclusion tests (e.g., GI contrast study, ultrasound).
- Metabolic/genetic conditions warrant exclusion in specific cases.
- Migraine-equivalent CVS shares features with migraine; pathophysiology involves neuronal hyperexcitability and autonomic dysregulation.
- Management includes lifestyle interventions and pharmacological therapies (abortive, supportive, prophylactic), with many responding to migraine-focused strategies.
Conclusions:
- CVS is a functional brain-gut disorder often managed disjointedly.
- Early recognition, evaluation, and management are crucial for improved outcomes.
- Further research is needed on CVS natural history, neuroendocrine mechanisms, and its relation to migraine.
Objectives/Background:
Cyclic vomiting syndrome (CVS) is a disabling disorder of gut-brain interaction manifested by stereotypical and severe episodes of nausea and vomiting. Prevalence data indicate that CVS affects 1-2% of children and there has been a recent dramatic rise in diagnosed adults.
Methods:
This narrative review summarizes relevant literature pertaining to pediatric and adult CVS and provides a guide to management based on extensive clinical experience.
Results:
More timely diagnosis is facilitated by an expert consensus diagnostic approach and limited testing. Some diagnostic tests of exclusion remain essential. These include an upper gastrointestinal (GI) contrast study to exclude intestinal malrotation and basic laboratory screening. An abdominal ultrasound is recommended to exclude renal hydronephrosis in children and biliary disease in adults. Exclusion of metabolic/genetic conditions is warranted in those with specific warning signs, presentation in infants/toddler age, and in those with refractory disease. In the absence of chronic GI symptoms, referral to a GI specialist for upper endoscopy is generally not necessary in children but recommended in adults. A large subset termed migraine-equivalent CVS display strong clinical and genetic features of migraine. A unifying pathophysiologic core concept involves neuronal hyperexcitability and aberrant central modulation of autonomic signals. This is coupled with multiple susceptibility factors including mitochondrial dysfunction/cellular energy deficits, a hyper-responsive hypothalamic-pituitary-adrenal axis and many comorbidities that increase vulnerability to triggering events. CVS episodes are frequently triggered by stressors and intercurrent illnesses. Lifestyle and non-pharmacological interventions thus play a pivotal role in successful management. Pharmacological therapies are categorized into abortive, supportive/rescue, and prophylactic treatments. The majority respond particularly well to migraine-focused treatment strategies.
Conclusion:
Despite improved characterization and understanding, CVS remains classified as a functional disorder of brain-gut interaction that is often disjointly managed by generalists and subspecialists. Early recognition, evaluation, and management will facilitate care and improve outcomes. Further research into its natural history with common progression to migraine headaches, neuroendocrine mechanisms, and the pathophysiologic relation to migraine diathesis is much needed.
Related Concept Videos
Pathophysiology of Vomiting
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Irritable Bowel Syndrome III: Medical and Nursing Management
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

